Myomo, Inc. (NYSE:MYO), a Healthcare Medical Devices business, saw its stock trade 30.04 shares, a surge when compared to its 10-day trading volume of 20.3k.
Myomo, Inc. (MYO) stock is quoted at $30.04, up 23.99 cents or +396.53% on the day. Based on this we can see some traders are either waiting on the sidelines to get involved or perhaps some are taking profits.
February 3, 2020 – Myomo, Inc. (NYSE American: MYO) announced that Statutory Health Insurance in Germany has approved MyoPro for patients on a case by case basis. A major German health insurer, BARMER, with 9 million covered lives, is covering the cost of the MyoPro provided through certified orthotics and prosthetics clinics in Germany.
January 30, 2020 — Myomo, Inc. (NYSE American: MYO), a commercial stage medical robotics company that offers expanded mobility for those suffering from neurological disorders and upper limb paralysis, today announced following approval of a reverse stock split range and authorized share reduction by stockholders at a special meeting of stockholders earlier today, Myomo’s Board of Directors determined to effect a reverse stock split of Myomo’s common stock at a ratio of one-for-thirty. The applicable Certificate of Amendment to the Company’s Eighth Amended and Restated Certificate of Incorporation, as amended, was filed with the Delaware Secretary of State today and will become effective at 5:00 p.m. Eastern Time on January 30, 2020.
Total Revenue for Myomo, Inc. (MYO) is $3.21M, Gross Profit is $1.72M and the EBITDA is $-10.86M.
Myomo, Inc. (MYO) Technical Evaluation:
The average 10-day trading volume of Myomo, Inc. (MYO) is 20.3k compared to 9.35k over the last 3 months which indicates a pullback in trading activity. At the time of writing this article, Myomo, Inc. (MYO) has a 50-day moving average of $9.55 and a 200-day moving average of $17.45. These moving averages are popular technical details that investors use to analyze price trends of Myomo, Inc. (MYO).
Technically, MYOs short term resistance level is $6.34 on the upside.
Based on technical analysis, MYO has short term rating of Neutral (-0.02), Intermediate rating of Neutral (0.14) and the long-term rating of Neutral (-0.01) giving it an overall rating of Neutral (0.03).
MYO is trading 458.56% off its 52 week low at $5.55 and -42.59% off its 52 week high of $54.00. Performance wise, MYO stock has recently shown investors -37.72% a pullback in a week, -32.96% a pullback in a month and -66.67% a pullback in the past quarter.
More importantly, Myomo, Inc. (MYO) has shown a return of -32.96% since the start of the year.
Myomo, Inc. (MYO) Key Data:
Myomo, Inc. (MYO) is a micro-cap company with a market cap value of $17.23M. MYO insiders hold roughly 8.32% of the shares.
On Oct-02-17 H.C. Wainwright Initiated MYO as Buy at $12.
There are currently 0.82M shares outstanding.
The industry rank for Myomo, Inc. (MYO) is 76 out of 254 ranking it at the Top 30% .
Myomo, Inc. (MYO) Fundamentals Statistics:
MYO last 2 years revenues have increased from $2,444 to $3,207 showing an uptrend.
Wall Street expects Myomo, Inc. (MYO) to report an EPS next Qtr loss of -4.80 and a profit of 53.80% next year.
The growth rate on MYO this year is 20.85 compared to an industry 1.30. However, MYOs next year’s growth rate is 62.39 compared to an industry 21.90.
The book value per share (mrq) is 0.26 and cash per share (mrq) is 5.24. Giving them a price/book (mrq) of 0.78 compared to an industry of 4.05 and
MYO fundamental ratios shows an EPS growth vs. previous year -19.97 and EPS growth vs. previous quarter -4.96.
About Myomo, Inc. (MYO):
Myomo, Inc. is a commercial stage medical robotics company. It offers expanded mobility which suffering from neurological disorders and upper limb paralysis. The company develops and markets the MyoPro(R) product line of lightweight, non-invasive, powered arm braces to restore function in the paralyzed or weakened arms and hands of individuals. Myomo, Inc. is headquartered in Cambridge,Massachusetts.